[Pharmacologic studies on the effect of N-(3-(1-benzyl-cycloheptyl-oxy)propyl)-N,N-dimethyl-ammonium-hydrogenfumarate].
D000661:Amphetamine / Q000494:pharmacology; D000779:Anesthetics, Local; D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects; D001775:Blood Circulation / Q000187:drug effects; D001831:Body Temperature; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D046508:Culture Techniques; D003508:Cycloheptanes / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D004285:Dogs; D005260:Female; D005650:Fumarates / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity; D006591:Hexobarbital; D008012:Lidocaine / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects; D009132:Muscles / Q000187:drug effects; D010208:Papaverine / Q000494:pharmacology; D010276:Parasympatholytics / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D011437:Propylamines / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D011680:Pupil / Q000187:drug effects; D051381:Rats; D014456:Ulcer; D014599:Uterus / Q000187:drug effects; D014665:Vasodilator Agents
D000779:Anesthetics, Local; D003508:Cycloheptanes; D005650:Fumarates; D010276:Parasympatholytics; D011437:Propylamines; D014665:Vasodilator Agents; D008012:Lidocaine; D006591:Hexobarbital; D000661:Amphetamine; D010208:Papaverine
Pharmakologische Untersuchungen über die Wirkung von N-(3-(1-Benzyl-cycloheptyl-oxy)-propyl)-N,N-dimethyl-ammonium-hydrogenfumarat.